Approval · Notice of Compliance 5171 · 1995
SYN-NITRAZEPAM: Notice of Compliance 5171
Issued December 19, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5171
- Date
- December 19, 1995
- Company
- Syncare Pharmaceutical Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Hypnotic and anticonvulsant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYN-NITRAZEPAM | 02200961 | — |
| SYN-NITRAZEPAM | 02200988 | — |
Medicinal ingredients
- NITRAZEPAM 5 MG per TAB
- NITRAZEPAM 10 MG per TAB